Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (633) Apply Human filter Veterinary (35) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Paediatric investigation plans Remove Paediatric investigation plans filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Withdrawn applications (67) Apply Withdrawn applications filter Orphan designations (216) Apply Orphan designations filter Referrals (7) Apply Referrals filter

Product number

Patient safety

Yes (5) Apply Yes filter

Authorisation status

Authorised (456) Apply Authorised filter Refused (17) Apply Refused filter Withdrawn (69) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (17) Apply Positive filter

Application type

Initial authorisation (9) Apply Initial authorisation filter Post-authorisation (8) Apply Post-authorisation filter

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (8) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (73) Apply PM: decision on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (18) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (10) Apply Yes filter

Compliance procedure number

Medicine type

Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (552) Apply Additional monitoring filter Conditional approval (73) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

668 results

Remove all filtersRemove all filters

Medicine type Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Accelerated assessment Remove Accelerated assessment filter Exceptional circumstances Remove Exceptional circumstances filter Biosimilar Remove Biosimilar filter

Medicine Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter Direct healthcare professional communication Remove Direct healthcare professional communication filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Sort by

List item

Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)

deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 26/09/2019, , Revision: 4, Authorised, Last updated: 13/04/2021
List item

Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka (updated)

emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 09/12/2016, , Revision: 9, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)

zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012, , Revision: 11, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Coagadex (updated)

Human coagulation factor X, Factor X Deficiency
Date of authorisation: 16/03/2016, , , , Revision: 7, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Opsumit (updated)

Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013, , Revision: 17, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK) (updated)

Pretomanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 31/07/2020, , , , Revision: 3, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Ogivri (updated)

trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 12/12/2018, , , Revision: 6, Authorised, Last updated: 09/04/2021
List item

Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)

olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007, , Revision: 28, Authorised, Last updated: 08/04/2021
List item

Human medicine European public assessment report (EPAR): Brineura (updated)

cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017, , , , , Revision: 5, Authorised, Last updated: 08/04/2021
List item

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)

efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018, , Revision: 6, Authorised, Last updated: 08/04/2021
List item

Human medicine European public assessment report (EPAR): Kymriah (updated)

tisagenlecleucel, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Large B-Cell, Diffuse
Date of authorisation: 22/08/2018, , , Revision: 4, Authorised, Last updated: 07/04/2021
List item

Human medicine European public assessment report (EPAR): Kisplyx (updated)

lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016, , , Revision: 13, Authorised, Last updated: 07/04/2021
List item

Human medicine European public assessment report (EPAR): Pemetrexed Hospira (updated)

pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 19/11/2015, , Revision: 11, Authorised, Last updated: 06/04/2021
List item

Human medicine European public assessment report (EPAR): Exviera (updated)

dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, , , Revision: 19, Authorised, Last updated: 06/04/2021
List item

Human medicine European public assessment report (EPAR): Cresemba (updated)

isavuconazole, Aspergillosis
Date of authorisation: 15/10/2015, , Revision: 10, Authorised, Last updated: 06/04/2021
List item

Human medicine European public assessment report (EPAR): Aybintio (updated)

bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020, , , Revision: 2, Authorised, Last updated: 06/04/2021
List item

Human medicine European public assessment report (EPAR): Ivozall (updated)

clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/11/2019, , Revision: 2, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Levetiracetam Teva (updated)

levetiracetam, Epilepsy
Date of authorisation: 25/08/2011, , Revision: 17, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Matever (updated)

levetiracetam, Epilepsy
Date of authorisation: 03/10/2011, , Revision: 22, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma (updated)

pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012, , Revision: 12, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Lenalidomide Mylan (updated)

lenalidomide, Multiple Myeloma
Date of authorisation: 18/12/2020, , Revision: 1, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Epclusa (updated)

Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016, , , Revision: 14, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories) (updated)

6-mercaptopurine monohydrate, Leukemia, Lymphoid
Date of authorisation: 09/03/2012, , Revision: 12, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Amglidia (updated)

glibenclamide, Diabetes Mellitus
Date of authorisation: 24/05/2018, , Revision: 4, Authorised, Last updated: 31/03/2021
List item

Human medicine European public assessment report (EPAR): Hulio (updated)

adalimumab, Hidradenitis Suppurativa, Psoriasis, Crohn Disease, Uveitis, Arthritis, Rheumatoid, Colitis, Ulcerative, Spondylitis, Ankylosing, Arthritis, Psoriatic
Date of authorisation: 16/09/2018, , , Revision: 5, Authorised, Last updated: 30/03/2021

Load more

668 results

Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)

Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka (updated)

Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)

Human medicine European public assessment report (EPAR): Coagadex (updated)

Human medicine European public assessment report (EPAR): Opsumit (updated)

Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK) (updated)

Human medicine European public assessment report (EPAR): Ogivri (updated)

Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)

Human medicine European public assessment report (EPAR): Brineura (updated)

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)

Human medicine European public assessment report (EPAR): Kymriah (updated)

Human medicine European public assessment report (EPAR): Kisplyx (updated)

Human medicine European public assessment report (EPAR): Pemetrexed Hospira (updated)

Human medicine European public assessment report (EPAR): Exviera (updated)

Human medicine European public assessment report (EPAR): Cresemba (updated)

Human medicine European public assessment report (EPAR): Aybintio (updated)

Human medicine European public assessment report (EPAR): Ivozall (updated)

Human medicine European public assessment report (EPAR): Levetiracetam Teva (updated)

Human medicine European public assessment report (EPAR): Matever (updated)

Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma (updated)

Human medicine European public assessment report (EPAR): Lenalidomide Mylan (updated)

Human medicine European public assessment report (EPAR): Epclusa (updated)

Human medicine European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories) (updated)

Human medicine European public assessment report (EPAR): Amglidia (updated)

Human medicine European public assessment report (EPAR): Hulio (updated)